Navigation Links
SL Industries Names Louis J. Belardi Chief Financial Officer
Date:9/2/2010

MT. LAUREL, N.J., Sept. 2 /PRNewswire-FirstCall/ --  SL Industries, Inc. (Amex: SLI) ("SLI" or the "Company") announced today that Louis J. Belardi has been named Chief Financial Officer, Secretary, and Treasurer of the Company, effective August 30, 2010.

"I am pleased to promote Lou to the CFO position at SLI," said William Fejes, Chief Executive Officer of the Company.  "Lou has been a key member of the SLI management team in his position as Corporate Controller since 2004.  His years of experience at SLI combined with his strong career experience in finance and administration make him uniquely qualified to step into the CFO job and play an important part in the future success of the Company. "

Prior to joining SL Industries in 2004, Mr. Belardi was a partner in his own management consulting firm that specialized in providing financial consulting to public corporations.  Before entering consulting, he was promoted through several financial roles to the position of Vice President Finance and Administration at Aydin Corporation, now part of L-3 Communications.  He also held finance positions in businesses in the health care and energy services industries.  Mr. Belardi started his career at Price Waterhouse.  He is a CPA and holds a Bachelor of Science degree from the University of Scranton and a Master's Degree in Finance from Temple University Graduate School.

About SL Industries

SL Industries, Inc. designs, manufactures and markets power electronics, power motion, power protection, teleprotection and communications equipment and systems that are used in a variety of medical, aerospace, computer, datacom, industrial, telecom, transportation and electric power utility equipment applications. For more information about SL Industries, Inc. and its products, please visit the Company's web site at

SOURCE SL Industries, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest and Conversion Rate Adjustment
2. Roper Industries Schedules Fourth Quarter 2009 Financial Results Conference Call
3. Roper Industries Announces Senior Subordinated Convertible Notes Due 2034 to Accrue Contingent Cash Interest
4. Roper Industries Completes the Acquisition of Verathon, Inc.
5. Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses
6. Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries
7. Prix Galien USA Honors Innovation in Science and Biotech Industries
8. Neptune Industries Reports Favorable Phase II Trial Results on Ento- Protein(TM)
9. BayCare Health System Names Tim Thompson Chief Information Officer
10. Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
11. K-V Pharmaceutical Names Thomas McHugh Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... April 2015 Hospira, Inc. ... Entwicklung von Biosimilar-Behandlungen, sprach heute auf der jährlichen ... (EGA) in London über ... Verfügbarkeit von Biosimilars für Patienten. Das ... Papers mit dem Titel „Why extrapolation is ...
(Date:4/24/2015)... 2015  Perrigo Company plc ("Perrigo" or the "Company") ... unsolicited offer from Mylan NV ("Mylan") (NASDAQ: MYL ... Perrigo for $60.00 per share in cash and 2.2 ... "Offer").  The Board previously concluded that ... the Company and its future growth prospects and was ...
(Date:4/24/2015)... HILL, N.C. , April 24, 2015 /PRNewswire/ ... the ability of consumers to educate themselves about ... expanded the tools and techniques available to market ... Given the changing consumer marketplace, it,s imperative that ... approaches to better identify market opportunities, niches and ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2
... -- La Jolla,Pharmaceutical Company today announced updated interim ... Riquent(R) (abetimus,sodium), its drug candidate for systemic lupus ... previous,conclusion that there is a definitive and significant ... 900 mg doses of Riquent compared,with placebo (p=0.0001). ...
... N.J., March 20, 2007 /PRNewswire-FirstCall/ --,Alfacell Corporation's ... a potent payload in antibody conjugates for ... the Handbook of Therapeutic,Antibodies. , In a ... Susanna,Rybak, Ph.D. summarizes preclinical research indicating that ...
Cached Medicine Technology:La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 2Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 3Alfacell's Onconase Highlighted in Latest Edition of Handbook of,Therapeutic Antibodies 4
(Date:4/25/2015)... ME (PRWEB) April 26, 2015 ... Canadian based integrative healthcare event. The Integrative Healthcare ... place October 23-24, 2015 at the Sheraton Parkway ... Symposium Canada is one of the most anticipated ... clinically relevant, evidenced-based CME program. The event aims ...
(Date:4/25/2015)... April 25, 2015 The federal ... mesh lawsuits filed against C.R. Bard, Inc. continues ... Southern District of West Virginia. According to a ... was convened that day, after certain defendants submitted ... Complaint. The Order directed that any Preliminary Motions ...
(Date:4/25/2015)... Illinois (PRWEB) April 25, 2015 ... enrichment and wellness, management and operations, and sales ... Meeting and Exhibition scheduled to be held from ... , LeadingAge Illinois is the largest eldercare association ... providers of services for older adults, including senior ...
(Date:4/25/2015)... April 25, 2015 For thirteen years, the ... income protection education event in the nation! This year, on ... Plus Group, US to take DI Day on the road ... G. Davidson, CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer ... Day reflects on the change by stating, "The first Twin ...
(Date:4/24/2015)... Foothill Ranch, California (PRWEB) April 24, 2015 ... that has a wide range of capabilities and services ... etc. , Ryadon's Quantity Discount Program will be ... ) as follows: , Order 4-19: Receive 10% discount ... Can Benefit by Using the Drawer Slides Products, ...
Breaking Medicine News(10 mins):Health News:Integrative Healthcare Event launching in Canada 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Gardant Management Solutions Staff Shares Operational Expertise 2Health News:Secura Consultants Takes DI Day On The Road 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 2Health News:Ryadon Inc. Offers Quantity Drawer Slide Discount Program Nationwide in May 2015 3
... from the University of Hull has told the British Psychological ... eating chocolate, lazing in front of the television, or going ... could make them more susceptible to disease.Those on the other ... to fight off infection.// ,Researchers asked 30 students ...
... a new gel, which works in a similar way to ... stomach each day, is being tested in four countries world-wide.For ... popping the contraceptive pill. But now there's a new option ... Association says "The gel is like any other gel, but ...
... in the devastated NewYork of America nor in the Afghanistan! It ... And who are the warring parties? They are the pharmaceutical industry ... Chemists Association. The latter is a member body of over 5,000 ... R Shah. // ,It is a classic case of ...
... Researchers in the US have found that genes contribute ... smoking. Chronic obstructive pulmonary disease (COPD), the name given ... because it leads to increasing shortness of breath. It's ... is a major cause of the problem.// ...
... the brain helps people recognise themselves in a picture, ... Deaconess Medical Center in Boston report their findings in ... a growing body of evidence that demonstrates the right ... self-awareness may provide unique insights into consciousness and doctors ...
... People who drink and smoke have to drink more ... greater risk of damage to their brains, livers and hearts, ... reduces blood alcohol levels in rats, which are considered a ... they will end up drinking more alcohol to get an ...
Cached Medicine News:Health News:The right is responsible 2
Straight shafts 4 mm platform. Wide serrated handle with dull finish. Platform angled 45 degrees....
Curved shafts with 3.5 mm angled platform and dull finish. Wide serrated handle with dull finish....
Double-ended. 10 mm sickle shaped blade. 27 mm blunt, curved double-edged blade....
Fixed smooth rod which slides on skin. Designated most popular model or size....
Medicine Products: